Search

Your search keyword '"Bergquist, Peter J."' showing total 9 results
Start Over Author "Bergquist, Peter J." Search Limiters Full Text
9 results on '"Bergquist, Peter J."'

2. Using machine learning to enhance prediction of atrial fibrillation recurrence after catheter ablation

Author

Brahier, Mark S., primary, Zou, Fengwei, additional, Abdulkareem, Musa, additional, Kochi, Shwetha, additional, Migliarese, Frank, additional, Thomaides, Athanasios, additional, Ma, Xiaoyang, additional, Wu, Colin, additional, Sandfort, Veit, additional, Bergquist, Peter J., additional, Srichai, Monvadi B., additional, Piccini, Jonathan P., additional, Petersen, Steffen E., additional, and Vargas, Jose D., additional

Published
2023
Full Text
View/download PDF

3. Quantification of Epicardial Adipose Tissue Volume and Attenuation for Cardiac CT Scans Using Deep Learning in a Single Multi-Task Framework

Author

Abdulkareem, Musa, primary, Brahier, Mark S., primary, Zou, Fengwei, primary, Rauseo, Elisa, primary, Uchegbu, Ijeoma, primary, Taylor, Alexandra, primary, Thomaides, Athanasios, primary, Bergquist, Peter J., primary, Srichai, Monvadi B., primary, Lee, Aaron M., primary, Vargas, Jose D., primary, and Petersen, Steffen E, primary

Published
2022
Full Text
View/download PDF

9. Remarkable Intracranial Response to Sotorasib in a Patient With KRAS G12C -Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case Report.

Author

Yeh J, Marks JA, Alzeer AH, Sloan EA, Varghese R, Paudel N, Reuss JE, Bergquist PJ, Liu SV, and Kim C

Abstract

Sotorasib is a KRAS G12C inhibitor that recently received approval for use in locally advanced or metastatic KRAS G12C -mutated NSCLC. CodeBreaK100, the phase 2 clinical trial leading to the approval of sotorasib, excluded patients with untreated brain metastases; there have been no reports describing efficacy of sotorasib on untreated brain metastases. We present a case of a patient with active untreated brain metastases with resulting disorientation and weakness who has radiographic response and complete resolution of neurologic symptoms with sotorasib. Our case illustrates the intracranial activity of sotorasib, but additional studies are needed to characterize the intracranial response rate and duration of response in these patients., (© 2022 The Authors.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results